Addex Therapeutics (NASDAQ: ADXN)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Addex Therapeutics (NASDAQ: ADXN) through any online brokerage.
The latest price target for Addex Therapeutics (NASDAQ: ADXN) was reported by HC Wainwright & Co. on Thursday, June 23, 2022. The analyst firm set a price target for 0.00 expecting ADXN to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Addex Therapeutics (NASDAQ: ADXN) is $1.1 last updated June 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for Addex Therapeutics.
Addex Therapeutics’s Q2 earnings are confirmed for Monday, August 1, 2022.
There is no upcoming split for Addex Therapeutics.
Addex Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.